Contrarius Investment Management LTD Natera, Inc. Transaction History

Contrarius Investment Management LTD

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2019 Aug 07, 2019	SELL	$17.75 - $27.58 $5.14 Million - $7.99 Million	-289,764 Closed	0 $0
Q1 2019 May 08, 2019	SELL	$11.34 - $20.62 $367,778 - $668,747	-32,432 Reduced 10.07%	289,764 $5.98 Million
Q4 2018 Feb 05, 2019	BUY	$12.32 - $24.38 $4,348 - $8,606	353 Added 0.11%	322,196 $4.5 Million
Q3 2018 Nov 09, 2018	SELL	$18.82 - $28.96 $2.4 Million - $3.69 Million	-127,467 Reduced 28.37%	321,843 $7.71 Million
Q2 2018 Aug 08, 2018	SELL	$8.79 - $19.98 $301,962 - $686,372	-34,353 Reduced 7.1%	449,310 $8.46 Million
Q1 2018 May 02, 2018	SELL	$9.0 - $11.95 $16,560 - $21,988	-1,840 Reduced 0.38%	483,663 $4.48 Million
Q4 2017 Feb 09, 2018	SELL	$8.99 - $14.31 $26,520 - $42,214	-2,950 Reduced 0.6%	485,503 $4.37 Million
Q3 2017 Nov 08, 2017	BUY	$8.02 - $13.33 $3.92 Million - $6.51 Million	488,453	488,453 $6.3 Million

528

119M

308K

191K

Ticker NTRA
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 96,957,400
Market Cap $16.3B
Description
Natera, Inc., a diagnostics company, develops and commercializes molecular testing services worldwide. It offers Panorama, a non-invasive prenatal test that screens for chromosomal abnormalities of a fetus with a blood draw from the mother, as well as twin pregnancies for zygosity; Vistara, a single-gene mutations screening test to identify sing...

Get notified when there are updates to the investment portfolio of Contrarius Investment Management LTD, based on Form 13F filings with the SEC.

Stay updated on Contrarius Investment Management LTD with notifications on news.